Related Articles
Reduced administration of rasburicase for tumor lysis syndrome: A single‑institution experience
Controlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndrome
Gemcitabine and cisplatin-induced tumor lysis syndrome in a patient with gallbladder carcinoma: A case report
Spontaneous tumor lysis syndrome in a patient with metastatic prostate cancer
FEC (FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE) PLUS GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR (GM-CSF) IN ADVANCED OR INFLAMMATORY BREAST-CANCER - A DOSE-FINDING STUDY